Semnur Pharmaceuticals, Inc. Earnings Per Share (Basic)
Semnur Pharmaceuticals, Inc. (SMNR) reported Earnings Per Share (Basic) of -$0.02 per share for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-10.
Financial Statements › Income Statement › Earnings Per Share
us-gaap:EarningsPerShareBasic · last filed 2026-08-10
- Semnur Pharmaceuticals, Inc. earnings per share, basic for the quarter ending 2026-06-30 was -$0.02.
- Semnur Pharmaceuticals, Inc. earnings per share, basic for the quarter ending 2026-03-31 was -$0.02.
- Semnur Pharmaceuticals, Inc. earnings per share, basic for the quarter ending 2025-12-31 was -$0.03.
- Semnur Pharmaceuticals, Inc. earnings per share, basic for the quarter ending 2025-09-30 was -$0.76.
| Period end | Earnings Per Share, Basic 3 month | Earnings Per Share, Basic 6 month | Earnings Per Share, Basic 9 month | Earnings Per Share, Basic 12 month |
|---|---|---|---|---|
| 2026-06-30 | -$0.02 10-Q · filed 2026-08-10 | -$0.04 10-Q · filed 2026-08-10 | -$0.07 derived: net income ÷ weighted average shares · filed 2026-08-10 | -$0.76 derived: net income ÷ weighted average shares · filed 2026-08-10 |
| 2026-03-31 | -$0.02 10-Q · filed 2026-05-13 | -$0.05 derived: net income ÷ weighted average shares · filed 2026-08-10 | -$0.75 derived: net income ÷ weighted average shares · filed 2026-08-10 | -$0.77 derived: net income ÷ weighted average shares · filed 2026-08-10 |
| 2025-12-31 | -$0.03 derived: net income ÷ weighted average shares · filed 2026-05-12 | -$0.76 derived: net income ÷ weighted average shares · filed 2026-05-12 | -$0.77 derived: net income ÷ weighted average shares · filed 2026-08-10 | -$0.78 S-1 · filed 2026-05-12 |
| 2025-09-30 | -$0.76 10-Q · filed 2025-11-12 | -$0.76 derived: net income ÷ weighted average shares · filed 2026-08-10 | -$0.77 10-Q · filed 2025-11-12 | -$0.77 derived: net income ÷ weighted average shares · filed 2026-08-10 |
| 2025-06-30 | -$0.01 10-Q · filed 2026-08-10 | -$0.01 10-Q · filed 2026-08-10 | -$0.01 derived: net income ÷ weighted average shares · filed 2026-08-10 | -$0.02 derived: net income ÷ weighted average shares · filed 2026-08-10 |
| 2025-03-31 | -$0.01 10-Q · filed 2026-05-13 | -$0.00 derived: net income ÷ weighted average shares · filed 2026-08-10 | -$0.01 derived: net income ÷ weighted average shares · filed 2026-08-10 | |
| 2024-12-31 | -$0.00 derived: net income ÷ weighted average shares · filed 2026-05-12 | -$0.01 derived: net income ÷ weighted average shares · filed 2026-05-12 | -$0.02 S-1 · filed 2026-05-12 | |
| 2024-09-30 | -$0.01 10-Q · filed 2025-11-12 | -$0.02 10-Q · filed 2025-11-12 |